NBM-BMX, an HDAC8 Inhibitor, Overcomes Temozolomide Resistance in Glioblastoma Multiforme by Downregulating the ß-Catenin/c-Myc/SOX2 Pathway and Upregulating p53-Mediated MGMT Inhibition.
Int J Mol Sci
; 22(11)2021 May 31.
Article
in En
| MEDLINE
| ID: mdl-34072831
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Repressor Proteins
/
DNA Modification Methylases
/
Tumor Suppressor Protein p53
/
Glioblastoma
/
Tumor Suppressor Proteins
/
DNA Repair Enzymes
/
Beta Catenin
/
Histone Deacetylases
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Int J Mol Sci
Year:
2021
Document type:
Article
Affiliation country:
Taiwan
Country of publication:
Switzerland